semaglutide

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Nov 11, 2025 by Dave Ricks · said 1 times in 1 episodes since 2025 · across every show →

Mentions by year

brought up most by Dave Ricks (1)

tap a year for its mentions
0011112025episodesmentions
0112025episodes it came up in
000.50.5112025episodesmentions per episode

every mention, scene by scene, with the transcript →

Everything said about semaglutide, oldest first

Nov 11, 2025 positive
Assertion Supported
Ricks: ICER found tirzepatide and semaglutide cost-effective at current pricing
“They just analyzed our medicines, trisepatide and semaglutide, and they said, actually, they're both cost effective at current pricing. In fact, Zepbound or Trisepatide was, the threshold they have is to save a 100,000 dollars per person per year in downstream…”
Dave Ricks Nov 11, 2025 ▶ 26:03 Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Made with StarZero

Turn any episode into a week of clips.

This entire site, about 28 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.